Mr Danny H Spitzberg, MD | |
8244 E Us Hwy 36, #200, Avon, IN 46123 | |
(317) 844-5500 | |
(317) 573-4230 |
Full Name | Mr Danny H Spitzberg |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 8244 E Us Hwy 36, Avon, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316975014 | NPI | - | NPPES |
100059280 | Medicaid | IN | |
000000390308 | Other | IN | BC/BS # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 01021242A (Indiana) | Primary |
207W00000X | Ophthalmology | 17641 (Arizona) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Mr Danny H Spitzberg, MD 8244 E Us Hwy 36, #200, Avon, IN 46123 Ph: (317) 272-2020 | Mr Danny H Spitzberg, MD 8244 E Us Hwy 36, #200, Avon, IN 46123 Ph: (317) 844-5500 |
News Archive
Transave, Inc., today reported positive results from a Phase II clinical trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The Phase II data indicated that ARIKACE, delivered once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by patient and physician reported outcomes and reduction in Pseudomonas aeruginosa density.
Tonsillectomies to treat chronic and recurrent tonsillitis substantially improve a patient's quality of live in both children and adults, according to two new studies published as a supplement to the January 2008 issue of Otolaryngology-Head and Neck Surgery.
The high‐performance capabilities of the HAMILTON‐C1 with the new Neonatal option include lung protective strategies and adaptive ventilation modes to ensure that each baby receives treatment tailored to its specific needs. Requiring only a minimum of space, the HAMILTON‐C1 combines high reliability, ease of use and maximum mobility with optimal performance for your most fragile patients.
Researchers at Southern Methodist University, Dallas, have discovered three new drug-like compounds that could ultimately offer better odds of survival to prostate cancer patients.
A new study has shown that the speed at which persons over 45 years of age walk could be an indicator of their brain and body age. The team of researchers from Duke University found that persons who walked slowly were more likely to have "accelerated aging" compared to those who walked faster.
› Verified 9 days ago
Darrel L Huff, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8244 E Us Highway 36, Suite 1270, Avon, IN 46123 Phone: 317-272-4242 Fax: 317-272-6640 |